Millrace Asset Group, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 299 filers reported holding HAEMONETICS CORP in Q4 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Millrace Asset Group, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2023$1,111
-35.6%
12,998
-32.5%
1.10%
-48.4%
Q3 2023$1,726
-2.1%
19,264
-7.0%
2.13%
+15.4%
Q2 2023$1,763
-99.8%
20,706
+109.7%
1.85%
+24.3%
Q1 2020$984,000
-41.6%
9,872
-32.7%
1.49%
-18.9%
Q4 2019$1,685,000
+17.2%
14,665
+28.6%
1.83%
+8.7%
Q3 2019$1,438,000
+32.8%
11,400
+26.7%
1.69%
+50.5%
Q2 2019$1,083,0009,0001.12%
Other shareholders
HAEMONETICS CORP shareholders Q4 2023
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders